Literature DB >> 6953461

Plasma levels, psychophysiological variables, and clinical response to amitriptyline.

U Breyer-Pfaff, H J Gaertner, H Giedke.   

Abstract

Hamilton depression scale ratings and physiological measurements were made for 37 patients with primary depression before treatment with amitriptyline (150 mg/day) and again after 2 and 4 weeks of treatment; plasma drug levels were determined weekly. Improvement was maximal at mean amitriptyline + nortriptyline concentrations of 125-200 ng/ml (14 patients), while at lower levels the outcome was significantly poorer (12 patients). Highly variable results were seen in 11 patients with levels between 200 and 301 ng/ml, with lesser improvement occurring in those patients who exhibited poor habituation of the skin resistance response before treatment. Other psychophysiological variables showed significant changes during treatment, but no correlation with clinical results or drug levels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6953461     DOI: 10.1016/0165-1781(82)90010-5

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

1.  Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression.

Authors:  Sven Ulrich; Jürgen Läuter
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysis.

Authors:  P J Perry; B M Pfohl; S G Holstad
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

3.  Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity.

Authors:  M L Rao
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Amitriptyline: linear or nonlinear kinetics in every day practice?

Authors:  S Vandel; G Bertschy; B Vandel; G Allers; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.

Authors:  H Giedke; H Gaertner; U Breyer-Pfaff; W Rein; D Axmann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

6.  Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice.

Authors:  B J Caldarone; K Karthigeyan; A Harrist; J G Hunsberger; E Wittmack; S L King; P Jatlow; M R Picciotto
Journal:  Psychopharmacology (Berl)       Date:  2003-07-15       Impact factor: 4.530

7.  Amitriptyline dosage prediction in elderly patients from plasma concentration at 24 hours after a single 100mg dose.

Authors:  S Dawling; S Ford; D C Rangedara; R R Lewis
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

8.  Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels.

Authors:  U Breyer-Pfaff; H J Gaertner; F Kreuter; G Scharek; M Brinkschulte; R Wiatr
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  Antidepressive effect of amitriptyline treatment with plasma drug levels controlled within three different ranges.

Authors:  J E Burch; O Ahmed; R P Hullin; R H Mindham
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.

Authors:  Pierre Baumann; Sven Ulrich; Gabriel Eckermann; Manfred Gerlach; Hans-Joachim Kuss; Gerd Laux; Bruno Müller-Oerlinghausen; Marie Luise Rao; Peter Riederer; Gerald Zernig; Christoph Hiemke
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.